Open with CtrlK — press Esc to close
Capillaries in living tissue sit a fraction of a millimeter apart, and that spacing is why lab-grown beef has stayed flat. Muscle grown in a dish has no plumbing inside it and starves in the middle,…
Engineers have sent data out of a mock brain implant as an electrical current through body tissue, with no wire and no antenna. They tested the link inside a human cadaveric head specimen. The system…
The case for DNA as an archive has been the same for a decade. It is denser than anything engineered, it keeps for centuries in the cold and the dark, and it draws no power while it sits there. The…
Somewhere in a chemical catalog sits a compound that nobody has ever dropped onto living cells while reading what happens to their genes. That is the ordinary case rather than the exception.…
The U.S. Food and Drug Administration said on Aug. 25 that it has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, a wearable sensor for people aged 2 and older…
The U.S. Food and Drug Administration has approved Rasonque (daraxonrasib), a tablet taken once a day, for adults with metastatic pancreatic adenocarcinoma, the agency announced Aug. 26. The approval…
The U.S. Food and Drug Administration has approved two regimens built around Ziihera (zanidatamab-hrii) as a first treatment for adults with HER2-positive gastroesophageal adenocarcinoma that cannot…
The U.S. Food and Drug Administration has placed a clinical hold on RGX-121, an experimental gene therapy for Hunter syndrome, and its developer says it no longer expects to resubmit the licensing…
Server racks do not usually need plumbing. The one at the National University of Singapore, demonstrated to guests on 6 August 2026 and announced on 17 August, has it in every unit: pumps, filters, a…
The U.S. Food and Drug Administration has cleared PrecivityAD2, a blood test that helps identify the amyloid plaques associated with Alzheimer's disease, its maker C2N Diagnostics said in a release…
The Food and Drug Administration granted accelerated approval Aug. 19 to Genglycos, a one-time gene therapy for glycogen storage disease type Ia, and said it is the first approved treatment for the…
A Phase 3 trial of Merck and Moderna's individualized mRNA cancer therapy, intismeran autogene, has met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant…